NFKB1 and maturity-onset diabetes of the young type 4: To gain insight into the molecular mechanisms that accelerate diabetes development upon NF-κB inhibition in our MODY4 model, we performed microarray-based gene expression analyses using isolated islets of early and progressed disease phases.